{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T03:06:40Z","timestamp":1785467200742,"version":"3.56.0"},"reference-count":51,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Hiroshima University\u2019s grant funding","award":["0G220"],"award-info":[{"award-number":["0G220"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dentistry Journal"],"abstract":"<jats:p>Background\/Objectives: Nisin A, an antimicrobial peptide produced by Lactococcus lactis, primarily shows antimicrobial activity against Gram-positive bacteria, with efficacy increased when used in combination with an antimicrobial drug. On the other hand, oral candidiasis, caused by Candida, occurs in immunocompromised patients and requires antifungal therapy. However, antifungal drug-resistant Candida strains are increasing worldwide, leading to serious problems. Methods: To examine the effects of nisin A against Candida species, we investigated the combined effects of nisin A and antifungal drugs on the growth and viability of Candida strains. Results: While nisin A alone had no antifungal effect, together with amphotericin (AMPH), it showed synergistic effects towards C. albicans, as well as the non-albican strains C. glabrata, C tropicalis, and C. parapsilosis in checkerboard assay results. Furthermore, nisin A with miconazole (MCZ) or micafungin (MCFG) demonstrated a synergistic or additive effect on those strains. Cell viability assay results showed that nisin A enhanced the fungicidal activity of AMPH against both C. albicans and C. glabrata. Biofilm reduction assays showed that nisin A with AMPH, MCZ, or MCFG inhibited biofilm activity against C. albicans as compared with each antifungal drug alone. Finally, nisin A with AMPH, MCZ, or MCFG resulted in a reduced minimum inhibitory concentration of those antifungal drugs against clinically isolated C. albicans and C. glabrata.Conclusions: When used in combination with nisin A, the antifungal drug dosage can be lowered, thus helping to prevent adverse side effects and the emergence of drug-resistant oral Candida species.<\/jats:p>","DOI":"10.3390\/dj13040160","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T03:32:53Z","timestamp":1744169573000},"page":"160","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effects of Nisin A Combined with Antifungal Drug Against Growth of Candida Species"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6150-0328","authenticated-orcid":false,"given":"Yoshie","family":"Niitani","sequence":"first","affiliation":[{"name":"Department of Oral Health Management, Program of Oral Health Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-Ku, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouji","family":"Ohta","sequence":"additional","affiliation":[{"name":"Department of Public Oral Health, Program of Oral Health Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-Ku, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Yano","sequence":"additional","affiliation":[{"name":"Department of Public Oral Health, Program of Oral Health Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-Ku, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1810-8891","authenticated-orcid":false,"given":"Yoshino","family":"Kaneyasu","sequence":"additional","affiliation":[{"name":"Department of Public Oral Health, Program of Oral Health Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-Ku, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0091-4457","authenticated-orcid":false,"given":"Tomoko","family":"Maehara","sequence":"additional","affiliation":[{"name":"Department of Public Oral Health, Program of Oral Health Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-Ku, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honami","family":"Kitasaki","sequence":"additional","affiliation":[{"name":"Department of Public Oral Health, Program of Oral Health Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-Ku, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Shigeishi","sequence":"additional","affiliation":[{"name":"Department of Public Oral Health, Program of Oral Health Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-Ku, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0741-9886","authenticated-orcid":false,"given":"Hiromi","family":"Nishi","sequence":"additional","affiliation":[{"name":"Department of General Dentistry, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-Ku, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumi","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Oral Epidemiology, Graduate of School Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3794-2643","authenticated-orcid":false,"given":"Mariko","family":"Naito","sequence":"additional","affiliation":[{"name":"Department of Oral Epidemiology, Graduate of School Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8011-5750","authenticated-orcid":false,"given":"Fumie","family":"Shiba","sequence":"additional","affiliation":[{"name":"Collaborative Research Laboratory of Oral Inflammation Regulation, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-Ku, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5593-5063","authenticated-orcid":false,"given":"Miki","family":"Kawada-Matsuo","sequence":"additional","affiliation":[{"name":"Department of Bacteriology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Komatsuzawa","sequence":"additional","affiliation":[{"name":"Department of Bacteriology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinobu","family":"Takemoto","sequence":"additional","affiliation":[{"name":"Department of Oral Health Management, Program of Oral Health Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-Ku, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00018-007-7171-2","article-title":"Biosynthesis, immunity, regulation, mode of action and engineering of the model lantibiotic nisin","volume":"65","author":"Lubelski","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tifs.2009.01.056","article-title":"Nisin biotechnological production and application: A review","volume":"20","author":"Luciana","year":"2009","journal-title":"Trends Food Sci. Technol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.mib.2008.09.008","article-title":"Therapeutic potential of type A (I) lantibiotics, a group of cationic peptide antibiotics","volume":"11","author":"Smith","year":"2008","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Campion, A., Casey, P.G., Field, D., Cotter, P.D., Hill, C., and Ross, R.P. (2013). In vivo activity of nisin A and nisin V against Listeria monocytogenes in mice. BMC Microbiol., 13.","DOI":"10.1186\/1471-2180-13-23"},{"key":"ref_5","unstructured":"Food and Drug Administration (1988). Nisin preparation: Affirmation of GRAS status as a direct human food ingredient. Fed. Regist., 53, 11247\u201311251."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/jam.13033","article-title":"Biomedical applications of nisin","volume":"120","author":"Shin","year":"2016","journal-title":"J. Appl. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/yea.3855","article-title":"Living together: The role of Candida albicans in the formation of polymicrobial biofilms in the oral cavity","volume":"40","author":"Surowiec","year":"2023","journal-title":"Yeast"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1177\/0961203314525247","article-title":"Oral candidiasis in systemic lupus erythematosus","volume":"23","author":"Fangtham","year":"2014","journal-title":"Lupus"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s12098-013-1201-x","article-title":"Recurrent oral thrush","volume":"81","author":"Sivabalan","year":"2014","journal-title":"Indian J. Pediatr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/668770","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009\u20132010","volume":"34","author":"Sievert","year":"2013","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_11","first-page":"279","article-title":"Clinical and microbiological diagnosis of oral candidiasis","volume":"5","year":"2013","journal-title":"J. Clin. Exp. Dent."},{"key":"ref_12","first-page":"1199","article-title":"Treatment of invasive candidiasis in the elderly: A review","volume":"8","author":"Flevari","year":"2013","journal-title":"Clin. Interv. Aging"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2147\/IDR.S80677","article-title":"Retrospective analysis of mortality and Candida isolates of 75 patients with candidemia: A single hospital experience","volume":"8","author":"Hirano","year":"2015","journal-title":"Infect. Drug Resist."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez de, U.M., Arbulu, S., Garcia-Gutierrez, E., and Cotter, P.D. (2020). Antifungal Peptides as Therapeutic Agents. Front. Cell Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.00105"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2300472","DOI":"10.1002\/advs.202300472","article-title":"Antimicrobial Peptide Synergies for Fighting Infectious Diseases","volume":"10","author":"Mhlongo","year":"2023","journal-title":"Adv. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Wang, J., Ma, X., Li, J., Shi, L., Liu, L., Hou, X., Jiang, S., Li, P., Lv, J., and Han, L. (2023). The Synergistic Antimicrobial Effect and Mechanism of Nisin and Oxacillin against Methicillin-Resistant Staphylococcus aureus. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076697"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s12602-009-9033-8","article-title":"Nisin A and Polymyxin B as Synergistic Inhibitors of Gram-positive and Gram-negative Bacteria","volume":"2","author":"Naghmouchi","year":"2010","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Field, D., Seisling, N., Cotter, P.D., Ross, R.P., and Hill, C. (2016). Synergistic Nisin-Polymyxin Combinations for the Control of Pseudomonas Biofilm Formation. Front. Microbiol., 7.","DOI":"10.3389\/fmicb.2016.01713"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ijantimicag.2019.03.009","article-title":"Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii","volume":"53","author":"Thomas","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/j.1365-2672.2008.03908.x","article-title":"Nisin Z inhibits the growth of Candida albicans and its transition from blastospore to hyphal form","volume":"105","author":"Le","year":"2008","journal-title":"J. Appl. Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Gao, S., Ji, Y., Xu, S., Jia, J., Fan, B., Zhang, Y., Shen, H., and Zhou, W. (2024). Antifungal activity of nisin against clinical isolates of azole-resistant Candida tropicalis. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1383953"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kadosh, D., and Mundodi, V. (2020). A Re-Evaluation of the Relationship between Morphology and Pathogenicity in Candida Species. J. Fungi, 6.","DOI":"10.3390\/jof6010013"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbrc.2006.07.066","article-title":"Hyphal formation of Candida albicans is controlled by electron transfer system","volume":"348","author":"Watanabe","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7150\/ijbs.5.153","article-title":"Activity of Chitosans in combination with antibiotics in Pseudomonas aeruginosa","volume":"5","author":"Tin","year":"2009","journal-title":"Int. J. Biol. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jneuroim.2010.11.009","article-title":"Additive effects of orexin B and vasoactive intestinal polypeptide on LL-37-mediated antimicrobial activities","volume":"233","author":"Ohta","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"ref_26","unstructured":"CLSI (2008). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, Clinical and Laboratory Standards Institute. [3rd ed.]. CLSI standard M27-A."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1128\/IAI.71.7.3730-3739.2003","article-title":"Staphylococcus aureus Susceptibility to Innate Antimicrobial Peptides, beta-Defensins and CAP18, Expressed by Human Keratinocytes","volume":"71","author":"Midorikawa","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1574-695X.2010.00734.x","article-title":"CX3CL1 expression induced by Candida albicans in oral fibroblasts","volume":"60","author":"Midorikawa","year":"2010","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e20210321","DOI":"10.1590\/1678-7757-2021-0321","article-title":"Expression of anti-fungal peptide, \u03b2-defensin 118 in oral fibroblasts induced by C. albicans \u03b2-glucan-containing particles","volume":"30","author":"Sakuma","year":"2022","journal-title":"J. Appl. Oral Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0005-2728(02)00308-0","article-title":"Characterization of the mitochondrial respiratory pathways in Candida albicans","volume":"1556","author":"Helmerhorst","year":"2002","journal-title":"Biochim. Biophys. Acta (BBA)-Bioenerg."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Kamikawa, Y., Mori, Y., Nagayama, T., Fujisaki, J., Hirabayashi, D., Sakamoto, R., Hamada, T., and Sugihara, K. (2014). Frequency of clinically isolated strains of oral Candida species at Kagoshima University Hospital, Japan, and their susceptibility to antifungal drugs in 2006-2007 and 2012-2013. BMC Oral Health, 14.","DOI":"10.1186\/1472-6831-14-14"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1439-0507.2011.02076.x","article-title":"Antifungal susceptibility of Candida albicans in biofilms","volume":"55","author":"Tobudic","year":"2012","journal-title":"Mycoses"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1128\/iai.62.3.915-921.1994","article-title":"Biofilm formation by Candida species on the surface of catheter materials in vitro","volume":"62","author":"Hawser","year":"1994","journal-title":"Infect. Immun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femsre\/fuad023","article-title":"After a century of nisin research\u2014Where are we now?","volume":"47","author":"Field","year":"2023","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/j.1365-2672.2009.04312.x","article-title":"In vitro efficacy of nisin Z against Candida albicans adhesion and transition following contact with normal human gingival cells","volume":"107","author":"Akerey","year":"2009","journal-title":"Appl. Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Singh, A.P., Prabha, V., and Rishi, P. (2013). Value addition in the efficacy of conventional antibiotics by nisin against Salmonella. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076844"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1074\/jbc.M006770200","article-title":"Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity","volume":"276","author":"Wiedemann","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Mesa-Arango, A.C., Scorzoni, L., and Zaragoza, O. (2012). It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug. Front. Microbiol., 3.","DOI":"10.3389\/fmicb.2012.00286"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1128\/AAC.40.2.279","article-title":"Antifungal agents: Chemotherapeutic targets and immunologic strategies","volume":"40","author":"Georgopapadakou","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.2165\/00003495-200868150-00010","article-title":"Micafungin: A review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections","volume":"68","author":"Cross","year":"2008","journal-title":"Drugs"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Cavalheiro, M., and Teixeira, M.C. (2018). Candida Biofilms: Threats, Challenges, and Promising Strategies. Front. Med., 5.","DOI":"10.3389\/fmed.2018.00028"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/21505594.2020.1748930","article-title":"The regulation of hyphae growth in Candida albicans","volume":"11","author":"Chen","year":"2020","journal-title":"Virulence"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/jac\/43.3.411","article-title":"Comparisons of the effects of fungicidal and fungistatic antifungal agents on the morphogenetic transformation of Candida albicans","volume":"43","author":"Hawser","year":"1999","journal-title":"Antimicrob. Chemother."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Whaley, S.G., Berkow, E.L., Rybak, J.M., Nishimoto, A.T., Barker, K.S., and Rogers, P.D. (2017). Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species. Front. Microbiol., 7.","DOI":"10.3389\/fmicb.2016.02173"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Rabaan, A.A., Sulaiman, T., Al-Ahmed, S.H., Buhaliqah, Z.A., Buhaliqah, A.A., AlYuosof, B., Alfaresi, M., Al, F.M.A., Alwarthan, S., and Alkathlan, M.S. (2023). Potential Strategies to Control the Risk of Antifungal Resistance in Humans: A Comprehensive Review. Antibiotics, 12.","DOI":"10.3390\/antibiotics12030608"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jiph.2022.08.004","article-title":"Development and research progress of anti-drug resistant fungal drugs","volume":"15","author":"Cui","year":"2022","journal-title":"J. Infect. Public Health"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Yang, Y.L., Xiang, Z.J., Yang, J.H., Wang, W.J., Xu, Z.C., and Xiang, R.L. (2021). Adverse Effects Associated with Currently Commonly Used Antifungal Agents: A Network Meta-Analysis and Systematic Review. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.697330"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Jesus, C., Soares, R., Cunha, E., Grilo, M., Tavares, L., and Oliveira, M. (2021). Influence of Nisin-Biogel at Subinhibitory Concentrations on Virulence Expression in Staphylococcus aureus Isolates from Diabetic Foot Infections. Antibiotics, 10.","DOI":"10.3390\/antibiotics10121501"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Kawada-Matsuo, M., Watanabe, A., Arii, K., Oogai, Y., Noguchi, K., Miyawaki, S., Hayashi, T., and Komatsuzawa, H. (2020). Staphylococcus aureus Virulence Affected by an Alternative Nisin A Resistance Mechanism. Appl. Environ. Microbiol., 86.","DOI":"10.1128\/AEM.02923-19"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Kawada-Matsuo, M., Yoshida, Y., Zendo, T., Nagao, J., Oogai, Y., Nakamura, Y., Sonomoto, K., Nakamura, N., and Komatsuzawa, H. (2013). Three distinct two-component systems are involved in resistance to the class I bacteriocins, Nukacin ISK-1 and nisin A, in Staphylococcus aureus. PLoS ONE, 86.","DOI":"10.1371\/journal.pone.0069455"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.idairyj.2005.10.026","article-title":"Bacteriocins: Biological tools for bio-preservation and shelf-life extension","volume":"16","author":"Deegan","year":"2006","journal-title":"Int. Dairy J."}],"container-title":["Dentistry Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2304-6767\/13\/4\/160\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:12:51Z","timestamp":1760029971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2304-6767\/13\/4\/160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":51,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["dj13040160"],"URL":"https:\/\/doi.org\/10.3390\/dj13040160","relation":{},"ISSN":["2304-6767"],"issn-type":[{"value":"2304-6767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]}}}